Optibrium Appoints Head of North American Operations

The opening of an office in Cambridge MA, along with the appointment of DrTamsin Manley to head its North American operations at the new facility, has marked the next phase in Optibrium’s expansion plans and business growth which havebeen driven by the uptake of its StarDrop™ software.

Supporting the company’s existing client base, Dr Manley will lead the development of new business opportunities for StarDrop and the company’s full range of products for small molecule design, optimisation and data analysis. Having worked for over 10 years developing, supporting and selling computational modelling and chemoinformatics software, Dr Manley also conducted post-doctoral research at the University of Texas and has experience as a medicinal chemist at Eli Lilly and UCB Research.

Tamsin commented, “I am excited to join Optibrium and looking forward to working with both existing and new clients, and supporting the Optibrium community across North America. I have a great respect for Optibrium’s strong scientific focus and vision for the future development of its products.”

Matthew Segall, CEO of Optibrium, commented, “Engaging with and supporting our users is Optibrium’s top priority and this exciting development enables us to enhance our ability to provide local support in North America. Tamsin’s appointment and the expansion of our team of scientists, celebrates the company’s success.”